Status: Not yet recruiting
Terazosin for Dementia With Lewy Bodies
The TZ-DLB trial will be a 3:2 (active:placebo) randomized, double-blind, placebo-controlled Pilot trial to evaluate the tolerability of terazosin for the treatment of dementia with Lewy bodies.
Participants needed: 40
Trial details
Phase: Phase 1, Phase 2Age: 0-90Biological sex: AllType: InterventionalSponsor: Qiang ZhangUpdated: Mar 12, 2026Locations: 1
Eligibility criteria
Men or women with the diagnosis of dementia with Lewy Bodies per 2017 DLB Consor... [+1]
Subjects unwilling or unable to give informed consent [+10]